Erythema

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2014-11-06
Clinical Trial Update: Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Persistent Facial Erythema [Phase 3]
The document notes that the Phase 3 study of CD07805/47 topical gel for persistent facial erythema has been withdrawn.